Repositorio Dspace

Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations

Mostrar el registro sencillo del ítem

dc.contributor.author Álvarez-García, Francisco-José
dc.contributor.author Cilleruelo-Ortega, María-José
dc.contributor.author Álvarez-Aldean, Javier
dc.contributor.author Garces-Sánchez, María
dc.contributor.author García-Sánchez, Nuria
dc.contributor.author Garrote-Llanos, Elisa
dc.contributor.author Hernández-Merino, Ángel
dc.contributor.author Iofrio-de-Arce, Antonio
dc.contributor.author Merino-Moina, Manuel
dc.contributor.author Montesdeoca-Melian, Abian
dc.contributor.author Navarro-Gómez, María-Luisa
dc.contributor.author Ruiz-Contreras, Jesús
dc.date.accessioned 2025-05-09T10:02:40Z
dc.date.available 2025-05-09T10:02:40Z
dc.date.issued 2020-01
dc.identifier.citation Álvarez García FJ, Cilleruelo Ortega MJ, Álvarez Aldeán J, Garcés-Sánchez M, García Sánchez N, Garrote Llanos E, et al. [Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations]. An Pediatr (Engl Ed). enero de 2020;92(1):52.e1-52.e10.
dc.identifier.issn 1695-4033
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/18948
dc.description.abstract The CAV-AEP annually publishes the immunisation schedule considered optimal for all children resident in Spain, taking into account the available evidence. The 2+1 schedule is recommended (2, 4, and 11 months) with hexavalent vaccines (DTPa-VPI-Hib-HB) and with 13-valent pneumococcal conjugate. A 6-year booster is recommended, preferably with DTPa (if available), with a dose of polio for those who received 2+1 schemes, as well as vaccination with Tdpa in adolescents and in each pregnancy, preferably between 27 and 32 weeks. Rotavirus vaccine should be systematic for all infants. Meningococcal B vaccine, with a 2+1 schedule, should be included in routine calendar. In addition to the inclusion of the conjugated tetravalent meningococcal vaccine (MenACWY) at 12 years of age with catch up to 18 years, inclusive, the CAV recommends this vaccine to be also included at 12 months of age, replacing MenC. Likewise, it is recommended in those over 6 weeks of age with risk factors or who travel to countries with a high incidence of these serogroups. Two-dose schedules for MMR (12 months and 3-4 years) and varicella (15 months and 3-4 years) will be used. The second dose could be applied as a tetraviral vaccine. Universal systematic vaccination against HPV is recommended, both for girls and boys, preferably at 12 years, and greater effort should be made to improve coverage. The 9 genotype extends coverage for both genders.
dc.language.iso spa
dc.publisher EDICIONES DOYMA S A
dc.rights Atribución-NoComercial-SinDerivadas 4.0 España
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Adolescent
dc.subject.mesh Bacterial Vaccines/administration & dosage
dc.subject.mesh Child
dc.subject.mesh Female
dc.subject.mesh Humans
dc.subject.mesh Immunization Schedule
dc.subject.mesh Infant
dc.subject.mesh Male
dc.subject.mesh Pediatrics
dc.subject.mesh Societies, Medical
dc.subject.mesh Spain
dc.subject.mesh Viral Vaccines/administration & dosage
dc.title Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 31901289
dc.relation.publisherversion https://dx.doi.org/10.1016/j.anpedi.2019.10.007
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1016/j.anpedi.2019.10.007
dc.journal.title Anales De Pediatria
dc.identifier.essn 1696-4608


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 4.0 España Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 4.0 España

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta